Harry M. Jansen Kraemer, Jr. Buys 43,000 Shares of Option Care Health, Inc. (NASDAQ:OPCH) Stock

Option Care Health, Inc. (NASDAQ:OPCH) Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of Option Care Health stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Option Care Health Stock Down 2.9 %

OPCH traded down $0.67 during mid-day trading on Wednesday, reaching $22.18. 1,969,110 shares of the stock were exchanged, compared to its average volume of 1,514,727. The company has a 50 day moving average price of $29.24 and a two-hundred day moving average price of $29.54. The stock has a market capitalization of $3.77 billion, a PE ratio of 18.80, a price-to-earnings-growth ratio of 2.37 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 1 year low of $22.11 and a 1 year high of $34.63.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Truist Financial decreased their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors have recently added to or reduced their stakes in OPCH. FMR LLC boosted its stake in shares of Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares during the last quarter. Westfield Capital Management Co. LP lifted its holdings in Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares during the period. Thrivent Financial for Lutherans boosted its position in Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after purchasing an additional 404,811 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Option Care Health by 6.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock valued at $99,870,000 after purchasing an additional 218,844 shares during the period. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Option Care Health by 2.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company’s stock valued at $78,842,000 after purchasing an additional 63,955 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.